
Britizilam 25mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Brivaracetam (25mg)
Overview Britizilam 25mg Tablet
Epileptic seizures are managed with the anticonvulsant medication, Britizilam 25mg Tablet. This medication, administered alone or in conjunction with other treatments, controls seizures by suppressing aberrant brain electrical activity, providing ongoing seizure prevention with consistent use. Taken regularly, with or without food, consistent daily timing maximizes effectiveness. Dosage frequency is individually determined by your physician to optimize seizure control and may be incrementally adjusted. Long-term use is typically recommended; continued adherence to the prescribed regimen, even during symptom-free periods, is crucial to prevent seizure exacerbation. Discontinuation should only occur under medical supervision, as abrupt cessation can worsen seizures. Common side effects, such as nausea, vomiting, headache, and dizziness, may occur, along with potential behavioral changes like irritability or aggression. These are often more pronounced initially and generally subside. While most side effects are minor, some are serious. Suicidal ideation has been reported in a small percentage of patients; worsening mood requires immediate medical consultation. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, depression, suicidal thoughts, pregnancy, or pregnancy plans to your physician. Breastfeeding mothers should also seek medical advice before using Britizilam.
Primary Ingredients of Britizilam 25mg Tablet
No text provided to rephrase.
Uses of Britizilam 25mg Tablet
Convulsive disorders
Major Benefits of Britizilam 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 25mg Britizilam tablet should be swallowed whole; do not chew, crush, or break it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Britizilam 25mg Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Britizilam 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg Britizilam tablet whole; do not damage it by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
How Britizilam 25mg Tablet works:
The anticonvulsant Britizilam, available in 25mg tablets, functions by binding to SV2A receptors located on neuronal membranes. This binding action inhibits excessive neuronal firing within the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Britizilam 25mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Britizilam 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Britizilam 25mg Tablet while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 25mg Britizilam tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Britizilam 25mg tablets are considered safe, and no dosage alteration is necessary. However, their use is not advised in cases of end-stage renal disease, owing to insufficient clinical study data.
LiverCAUTION
Patients with hepatic impairment should use Britizilam 25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Britizilam 25mg Tablet :
NA
Facts to Know About Britizilam 25mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Action Class | AED: A protein ligand within synaptic vesicle 2 |
